The Use of Artificial Intelligence in the Management of Neurodegenerative Disorders; Focus on Alzheimer's Disease.
Galen Med J
; 12: 1-7, 2023.
Article
en En
| MEDLINE
| ID: mdl-38827644
ABSTRACT
Recent advances in artificial intelligence (AI) have shown great promise in the diagnosis, prediction, treatment plans, and monitoring of neurodegenerative disorders. AI algorithms can analyze huge quantities of data from numerous sources, including medical images, quantifiable proteins in urine, blood, and cerebrospinal fluid (CSF), genetic information, clinical records, electroencephalography (EEG) signals, driving behaviors, and so forth. Alzheimer's disease (AD) is one of the most common neurodegenerative disorders that progressively damage cognitive abilities and memory. This study specifically explores the possible application of AI in the diagnosis, prediction, monitoring, biomarker or drug discovery, and classification of AD.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Galen Med J
Año:
2023
Tipo del documento:
Article
País de afiliación:
Irán
Pais de publicación:
Irán